Albert Einstein College of Medicine (US)
Access 250+ million papers and cite this researcher's work with AI assistance
H-index
130
Publications
2089
Citations
70286
i10-index
738
Want to find and read papers by this researcher? AnswerThis gives you instant access.
Sign Up Free| Title | Year | Citations |
|---|---|---|
Azacitidine and Venetoclax in Previously Untreated... | 2020 | 2668 |
Venetoclax combined with decitabine or azacitidine... | 2018 | 1826 |
Targetable Kinase-Activating Lesions in Ph-like Ac... | 2014 | 1367 |
Efficacy and Biological Correlates of Response in ... | 2016 | 1040 |
Mechanisms of apoptosis sensitivity and resistance... | 2006 | 1008 |
An inhibitor of oxidative phosphorylation exploits... | 2018 | 927 |
Acute myeloid leukemia: current progress and futur... | 2021 | 733 |
Selective BCL-2 Inhibition by ABT-199 Causes On-Ta... | 2013 | 726 |
Safety and preliminary efficacy of venetoclax with... | 2018 | 701 |
Pharmacologic inhibition of fatty acid oxidation s... | 2009 | 692 |
Marina Konopleva is a researcher with 2089 publications and 70286 citations. They are affiliated with Albert Einstein College of Medicine. Their research focuses on . With an h-index of 130, they are among the top researchers in their field.
Distribution of citations across publications
AnswerThis uses AI to help you search, understand, and cite research from Marina Konopleva and 250M+ other papers.
Citations per publication by year